EcoGenome is a life science company focusing on the development of tests that enhance personalized treatment strategies for cancer patients.
EcoGenome has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in November 2022.
EcoGenome is headquartered in Doylestown, United States.
EcoGenome is a life science company focusing on the development of tests that enhance personalized treatment strategies for cancer patients.
EcoGenome is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EcoGenome — Funding & Investors." VCBacked, November 3, 2022, https://www.vcbacked.co/company/ecogenome. Accessed August 14, 2026.
VCBacked. (2022). EcoGenome — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ecogenome
{{cite web |title=EcoGenome — Funding & Investors |url=https://www.vcbacked.co/company/ecogenome |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated